<DOC>
	<DOCNO>NCT02638597</DOCNO>
	<brief_summary>This project test whether gemfibrozil , well-studied medication high cholesterol , help people stop smoke nicotine cigarette smoking . The study also test whether gemfibrozil decrease craving cigarette desire smoke .</brief_summary>
	<brief_title>Gemfibrozil Nicotine Smoking Cessation</brief_title>
	<detailed_description>This pilot clinical trial examine feasibility efficacy gemfibrozil treatment smoke cessation . Adults desire quit nicotine cigarette smoking recruit . Eligible participant randomly divide two group : receive gemfibrozil waitlist control . Screening conducted brief phone screen follow longer screen visit qualify . During screen visit , study participant provide demographic information interview regard smoke history . Procedures perform screen visit include blood draw , urine pregnancy test , physical exam , clinical psychiatric interview , measurement exhale carbon monoxide ( CO ) . At baseline , participant complete Heavy Smoking Index ( HSI ) Brief Questionnaire Smoking Urges ( QSU-Brief ) . Participants also complete Quick Inventory Depressive Symptoms-Self Rated ( QIDS-SR ) ass symptom depression change mood associated smoking cessation assess Concise Associated Symptoms Tracking ( CAST ) scale . Participants work research clinician set target quit date within one week baseline session , participant provide write material guidance smoke cessation part smoke cessation counseling session . All participant attend visit research clinic 3 day 4 week target quit date ass safety , adherence , smoke status ; participant also receive additional smoking cessation counseling . Smoking status determine exhale breath CO single item questionnaire regard number cigarette smoke since target quit date symptom depression mood change measure . Medication side effect quantify use Frequency , Intensity , Burden Side Effects Rating ( FIBSER ) scale . The final study visit occur 8 week target quit date completion HSI , QIDS-SR , CAST , FIBSER , exhale breath CO , QSU-Brief , smoke self-report .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>Age 1864 year Meet DSM5 criterion tobacco use disorder base cigarette use Desire quit smoke Able complete assessment interview English Psychiatric comorbidity pose safety risk , include current suicidality psychosis assess clinical interview Concurrent use statin medication ( HMGCoA reductase inhibitor ) , anticoagulant , repaglinide Concurrent use FDAapproved medication smoke cessation Use form tobacco nicotine ( include vaporizer ) cigarette smoke Any DSM5 substance use disorder nicotine use disorder History intolerance fibrate medication History gallbladder disease cholestectomy perform Baseline liver function test &gt; twice upper limit normal Severe impairment renal function ( baseline serum creatinine â‰¥ 2 mg/dL ) Currently pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>